"The risk of depression following a diagnosis of diabetes falls during the second decade of having the disease and then rapidly rises, Australian researchers have discovered, in a study that suggests there is a J-shaped relationship between the tw"...
NARDIL (phenelzine) has been found to be effective in depressed patients clinically characterized as “atypical,” “nonendogenous,” or “neurotic.” These patients often have mixed anxiety and depression and phobic or hypochondriacal features. There is less conclusive evidence of its usefulness with severely depressed patients with endogenous features.
NARDIL (phenelzine) should rarely be the first antidepressant drug used. Rather, it is more suitable for use with patients who have failed to respond to the drugs more commonly used for these conditions.
DOSAGE AND ADMINISTRATION
Initial dose: The usual starting dose of NARDIL (phenelzine) is one tablet (15 mg) three times a day.
Early phase treatment: Dosage should be increased to at least 60 mg per day at a fairly rapid pace consistent with patient tolerance. It may be necessary to increase dosage up to 90 mg per day to obtain sufficient MAO inhibition. Many patients do not show a clinical response until treatment at 60 mg has been continued for at least 4 weeks.
Maintenance dose: After maximum benefit from NARDIL (phenelzine) is achieved, dosage should be reduced slowly over several weeks. Maintenance dose may be as low as one tablet, 15 mg, a day or every other day, and should be continued for as long as is required.
Each NARDIL (phenelzine) tablet is orange, biconvex, film-coated, and engraved with “P-D 270” and contains phenelzine sulfate equivalent to 15 mg of phenelzine base.
NDC 0071-0350-60. Bottle of 60
Store between 15° - 30°C (59° - 86°F).
Distributed by Parke-Davis., Division of Pfizer Inc, NY, NY 10017 Revised May 2007. FDA Rev date: 8/2/2007This monograph has been modified to include the generic and brand name in many instances.
Last reviewed on RxList: 8/29/2007
Additional Nardil Information
Nardil - User Reviews
Nardil User Reviews
Now you can gain knowledge and insight about a drug treatment with Patient Discussions.
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Get tips on therapy and treatment.